Skip to main content

Return of Tylenol


FORT WASHINGTON, Pa. — There's a lot of talk this year about the return of some venerable brand names in the OTC aisles, particularly Tylenol. But if the soft launch of McNeil Consumer's Children's Tylenol serves as any kind of barometer, the return of the brands will be a big deal. Without the expected marketing hype this fourth quarter, annualized sales of Children's Tylenol were up 31.8% to $51.4 million, securely resuming its claim as the best-selling children's fever reducer for the 52 weeks ended June 16 across total U.S. multi-outlets, according to IRI.

This ad will auto-close in 10 seconds